#ExpertTalk: CNM-Au8 Long-term Evidence & EAP Program Update | Rob Etherington & Dr. Marjan Sepassi
56:53
#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS
57:07
2025: New therapies and approaches in ALS : gene, small molecules, repair, and more
1:11:52
Pridopodine for treatment of ALS
57:02
Shifting the PARADIGM:PrimeC, an Oral Candidate for ALS
1:18:29
Repeat Associated Non-AUG (RAN) Proteins as Therapeutic Targets for C9orf72 ALS/FTD
14:32
CNM AU8 for Multiple Sclerosis 3-Year Data
21:01
Watch Trudeau speak directly to Trump during blistering speech
22:07